Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 856

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 856
---
 Conduit Pharmaceuticals Inc. common stock in connection with PIPE Financing 
     20,000 
  
    Exchange of Conduit Pharmaceuticals Limited ordinary shares for Conduit Pharmaceuticals Inc. common stock on the Closing Date 
     646,264 
  
    Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date 
     3,735 
  
    Issuance of Conduit Pharmaceuticals Inc. common stock to an advisor for services directly related to the Merger 
     13,000 
  
    Total - Conduit Pharmaceuticals Inc. common stock outstanding as a result of the Merger, PIPE Financing, exchange of Conduit Pharmaceuticals Limited shares for shares of Conduit Pharmaceuticals Inc., issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes, and advisors. 
     724,181 

    F-15

3.
Fair Value

During
the period ended December 31, 2024, there were no transfers between Level 1 and Level 2, nor into or out of Level 3. The following
table presents as of December 31, 2024 the Company’s assets and liabilities subject to measurement at fair value on a
recurring basis (in thousands):

 Schedule
of  Assets Subject to Measurement at Fair Value on Recurring Basis

    Fair Value Measurements as of December 31, 2024 

    Level 1  
    Level 2  
    Level 3  
    Total 
  
    Assets: 

    Cash equivalents 
    $192  
    $-  
    $-  
    $192 
  
    Total Assets 
    $192  
    $-  
    $-  
    $192 

    Liabilities: 

    Convertible notes payable at fair value 
    $-  
    $-  
    $5,856  
    $5,856 
  
    Liability Classified Warrants 
     -  
     0  
     138  
     138 
  
    Total Liabilities 
    $-  
    $-  
    $5,994  
    $5,994 

The
following table presents as of December 31, 2023 the Company’s liabilities subject to measurement at fair value on a recurring
basis (in thousands):

    Fair Value Measurements as of December 31, 2023 

    Level